GPD1L anticorps (AA 1-351)

N° du produit ABIN5776141

L’anticorps Souris Monoclonal anti-GPD1L a été validé pour WB, ELISA, ICC et IF. Il convient pour détecter GPD1L dans des échantillons de Humain.

Aperçu rapide pour GPD1L anticorps (AA 1-351) (ABIN5776141)

Antigène: GPD1L (Glycerol-3-Phosphate Dehydrogenase 1-Like (GPD1L))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp GPD1L est non-conjugé

Application: Western Blotting (WB), ELISA, Immunocytochemistry (ICC), Immunofluorescence (IF)

Clone: AT14E2

Détail du produit anti-GPD1L anticorps

Épitope: AA 1-351

Immunogène: Recombinant human GPD1L (1-351aa) purified from E. coli

Isotype: IgG1 kappa

Information d'application

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Stock: 4 °C,-20 °C,-80 °C

Stockage commentaire: Can be stored at +2°C to +8°C for 1 week. For long term storage, aliquot and store at -20°C to -80°C. Avoid repeated freezing and thawing cycles.

Détails sur GPD1L

Antigène: GPD1L (Glycerol-3-Phosphate Dehydrogenase 1-Like (GPD1L))

Autre désignation: GPD1L

Sujet: GPD1L is converts sn-glycerol 3-phosphate to glycerone phosphate. This protein is found in the cytoplasm, associated with the plasma membrane, where it binds the sodium channel, voltage-gated, type V, alpha subunit (SCN5A). GPD1L is thought to affect trafficking of the cardiac sodium current to the cell surface. Mutations in GPD1L are the cause of sudden infant death syndrome (SIDS) and Brugada syndrome type 2, an autosomal dominant tachyarrhythmia.

NCBI Accession: NP_055956